The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation
Open accessAbstract
BACKGROUND: Neurodegeneration with brain iron accumulation (NBIA) defines a group of genetic disorders characterized by brain iron deposition and associated with neuronal death. The known causes of NBIA include pantothenate kinase-associated neurodegeneration (PKAN), neuroferritinopathy, infantile neuroaxonal dystrophy (INAD), and aceruloplasminemia. OBJECTIVE: To define the radiologic features of each NBIA subtype. METHODS: Brain MRIs from patients with molecularly confirmed PKAN (26 cases), neuroferritinopathy (21 cases), INAD (four cases), and aceruloplasminemia (10 cases) were analyzed blindly to delineate patterns of iron deposition and neurodegeneration. RESULTS: In most cases of PKAN, abnormalities were restricted to globus pallidus and substantia nigra, with 100% having an eye of the tiger sign. In a minority of PKAN cases there was hypointensity of the dentate nuclei (1/5 on T2* sequences, 2/26 on fast spin echo [FSE]). In INAD, globus pallidus and substantia nigra were involved on T2* and FSE scans, with dentate involvement only seen on T2*. By contrast, neuroferritinopathy had consistent involvement of the dentate nuclei, globus pallidus, and putamen, with confluent areas of hyperintensity due to probable cavitation, involving the pallida and putamen in 52%, and a subset having lesions in caudate nuclei and thalami. More uniform involvement of all basal ganglia and the thalami was typical in aceruloplasminemia, but without cavitation. CONCLUSIONS: In the majority of cases, different subtypes of neurodegeneration associated with brain iron accumulation can be reliably distinguished with T2* and T2 fast spin echo brain MRI, leading to accurate clinical and subsequent molecular diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic, Clinical, and Radiographic Delineation of Hallervorden–Spatz Syndrome
Hayflick, S. J., Westaway, S. K., Levinson, B., Zhou, B., Johnson, M. A., Ching, K. H. L., & Gitschier, J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020817 · Cited by 714
Self-citationAceruloplasminemia: molecular characterization of this disorder of iron metabolism.
Harris, Z. L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R. T., & Gitlin, J. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2539 · Cited by 558
Curtis, A. R. J., Fey, C., Morris, C. M., Bindoff, L. A., Ince, P. G., Chinnery, P. F., Coulthard, A., Jackson, M. J., Jackson, A. P., McHale, D. P., et al. (2001) · Nature Genetics · doi:10.1038/ng571 · Cited by 537
Self-citationPLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron
Morgan, N. V., Westaway, S. K., Morton, J. E. V., Gregory, A., Gissen, P., Sonek, S., Cangul, H., Coryell, J., Canham, N., Nardocci, N., et al. (2006) · Nature Genetics · doi:10.1038/ng1826 · Cited by 533
Self-citationGelman, N., Gorell, J. M., Barker, P. B., Savage, R. M., Spickler, E. M., Windham, J. P., & Knight, R. A. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe41759 · Cited by 373
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation
Chinnery, P. F., Crompton, D. E., Birchall, D., Jackson, M. J., Coulthard, A., Lombes, A., Quinn, N., Wills, A., Fletcher, N., Mottershead, J. P., et al. (2006) · Brain · doi:10.1093/brain/awl319 · Cited by 205
Potential sources of increased iron in the substantia nigra of parkinsonian patients
Gerlach, M., Double, K. L., Youdim, M. B. H., & Riederer, P. F. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_21 · Cited by 112
Hereditary ceruloplasmin deficiency with hemosiderosis
Okamoto, N., Wada, S., Oga, T., Kawabata, Y., Baba, Y., Habu, D., Takeda, Z., & Wada, Y. (1996) · Human Genetics · doi:10.1007/bf02346185 · Cited by 112
Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights
Loréal, O., Turlin, B., Pigeon, C., Moisan, A., Ropert, M., Morice, P., Gandon, Y., Jouanolle, A., Vérin, M., Hider, R. C., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00042-9 · Cited by 106
House, M. J., Pierre, T. G. S., Kowdley, K. V., Montine, T. J., Connor, J. R., Beard, J., Berger, J., Siddaiah, N. B., Shankland, E. G., & Jin, L. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21118 · Cited by 105
Cited by
Susceptibility-Weighted Imaging: Technical Aspects and Clinical Applications, Part 2
Mittal, S., Wu, Z., Neelavalli, J., & Haacke, E. M. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1461 · Cited by 769
Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury
Farina, M., Avila, D. S., da Rocha, J. B. T., & Aschner, M. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.006 · Cited by 553
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Clinical and genetic delineation of neurodegeneration with brain iron accumulation
Gregory, A., Polster, B. J., & Hayflick, S. J. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061929 · Cited by 364
Self-citationKell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Metadata
- Authors
- McNeill, A., Birchall, D., Hayflick, S. J., Gregory, A., Schenk, J. F., Zimmerman, E. A., Shang, H., Miyajima, H., & Chinnery, P. F.
- Venue
- Neurology
- Published
- 2008-04-29
- Volume
- 70
- Issue
- 18
- Pages
- 1614-1619
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2066633780
- Cited by
- 302
- References
- 20
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. https://app.cochat.ai/papers/10.1212/01.wnl.0000310985.40011.d6
- The paper
- McNeill, A., Birchall, D., Hayflick, S. J., Gregory, A., Schenk, J. F., Zimmerman, E. A., Shang, H., Miyajima, H., & Chinnery, P. F. (2008). T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology. https://doi.org/10.1212/01.wnl.0000310985.40011.d6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.